H929 (HiBiT) Cell Bank from Promega

Supplier Page

Supplier Page from
Promega for
H929 (HiBiT) Cell Bank

Get Pricing

Description

HiBiT Target Cell Killing (TCK) Bioassays provide a flexible, reproducible, label-free, luminescent system for measuring the potency of a variety of cellular and immune-oncology drug products where target cell killing is a mechanism of action. With applications across a broad spectrum of next-generation biologics, including CAR-T cells, bispecific antibodies, and monoclonal antibodies, these assays deliver quantitative, gain-of-signal readouts with unmatched precision. When H929 (HT-HiBiT) target cells are cocultured with appropriate effector cells (e.g., CAR-T cells, PBMCs or cytotoxic T cells), they can be specifically used to monitor the activity of biologics directed against receptors expressed on the H929 Cells (HT-HiBiT), such as CD38 or BCMA